Company: ABBV
Filing Date: 2025-03-24
Form Type: DEF 14A
Source: 0001558370-25-003537
Chunk: 36

Company: AbbVie Inc.
Filing Date: 2025-03-24
Form: DEF 14A
Chunk 36
---
           | 24.6 BN | (3)  ​ |             105 | % |
| ​                            | ​ | ​ | ​ |   |             | ​       | ​ | 2024 Payout   |        |             |         |   |                 | ​ | ​ | Capped at 190% of target |   |             |         |        |                 | ​ |
| ​                            | ​ | ​ | ​ |   |             | ​       | ​ | Matrix Result |        |             |         |   |                 | ​ | ​ | -below 200% plan maximum |   |             |         |        |                 | ​ |

| (1) | Results achieved reflect certain specified items, which are reconciled in Appendix B. |

| (2) | Platform Revenue is a non-GAAP metric comprised of net revenues less total Humira sales and adjusted for foreign exchange, as outlined in Appendix B. The committee retained for 2024 the use of Platform Revenue, first introduced as a performance metric within the PIP in 2022, to reinforce management’s focus on growth opportunities to offset anticipated revenue decline associated with U.S. Humira loss of exclusivity (LOE). Platform Revenue target and result are adjusted for foreign exchange because it is unpredictable at the time the target is set. |

| (3) | Evaluated on a constant currency basis. |

The results for each of our NEOs are shown below.

|                       | ​ |              | ​    |             | ​     |                     |
| ​                     |   | Target Award |      |             |       |                   ​ |
| Executive             | ​ |      $ Value |      | % of Salary | ​     | $ Actual Award Paid |
| Robert A. Michael     | ​ |    2,550,000 | ​    |         150 | %     |           4,590,000 |
| Richard A. Gonzalez   | ​ |    2,452,500 | (1)​ |       152.5 | % (1) |           4,414,500 |
| Scott T. Reents       | ​ |    1,320,000 | ​    |         120 | %     |           2,250,000 |
| Jeffrey R. Stewart    | ​ |    1,545,000 | ​    |         120 | %     |           2,900,000 |
| Azita Saleki-Gerhardt |